SPN 150 (Qelbree 150 mg)
Generic Name: viloxazine
Pill with imprint SPN 150 is Purple, Capsule-shape and has been identified as Qelbree 150 mg. It is supplied by Supernus Pharmaceuticals, Inc.
Qelbree is used in the treatment of adhd and belongs to the drug class adrenergic uptake inhibitors for ADHD. Qelbree 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for SPN 150
Qelbree
- Generic Name
- viloxazine
- Imprint
- SPN 150
- Strength
- 150 mg
- Color
- Purple
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Adrenergic uptake inhibitors for ADHD
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Supernus Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 17772-0132
More about Qelbree (viloxazine)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (6)
- Drug images
- Pricing & coupons
- En español
- Drug class: adrenergic uptake inhibitors for ADHD
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.